(Q44952892)

English

Caspofungin as salvage monotherapy for invasive aspergillosis in patients with haematological malignancies or following allogeneic stem cell transplantation: efficacy and concomitant cyclosporin A.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Caspofungin as salvage monotherapy for invasive aspergillosis in patients with haematological malignancies or following allogeneic stem cell transplantation: efficacy and concomitant cyclosporin A. (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

0 references

invasive aspergillosis

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

author name string

C O Morrissey

1

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

M A O'Reilly

3

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

J R Daffy

4

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

J F Seymour

5

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

A P Schwarer

6

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

publication date

1 January 2007

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

50 Suppl 1

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

24-37

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2007.01377.X

21 January 2018

Risk factors for post-engraftment invasive aspergillosis in allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2007.01377.X

21 January 2018

Invasive mold infections in allogeneic bone marrow transplant recipients.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2007.01377.X

21 January 2018

Aspergillosis case-fatality rate: systematic review of the literature

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2007.01377.X

21 January 2018

Diagnostic yield of bronchoscopy in histologically proven invasive pulmonary aspergillosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2007.01377.X

21 January 2018

Diagnostic aspects of invasive Aspergillus infections in allogeneic BMT recipients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2007.01377.X

21 January 2018

Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2007.01377.X

21 January 2018

Human B cells that hyperexpress a triad of costimulatory molecules via avipox-vector infection: an alternative source of efficient antigen-presenting cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2007.01377.X

21 January 2018

Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2007.01377.X

21 January 2018

Mortality and costs of acute renal failure associated with amphotericin B therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2007.01377.X

21 January 2018

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2007.01377.X

21 January 2018

Amphotericin B lipid complex in the management of invasive aspergillosis in immunocompromised patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2007.01377.X

21 January 2018

Liposomal amphotericin B (AmBisome) therapy in invasive fungal infections. Evaluation of United Kingdom compassionate use data

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2007.01377.X

21 January 2018

Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2007.01377.X

21 January 2018

Salvage therapy with caspofungin for invasive aspergillosis: results from the caspofungin compassionate use study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2007.01377.X

21 January 2018

Caspofungin as second-line therapy for fever of unknown origin or invasive fungal infection following allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2007.01377.X

21 January 2018

Safety and tolerability of caspofungin acetate in the treatment of fungal infections

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2007.01377.X

21 January 2018

Retrospective study of the hepatic safety profile of patients concomitantly treated with caspofungin and cyclosporin A.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2007.01377.X

21 January 2018

Safety of the concomitant use of caspofungin and cyclosporin A in patients with invasive fungal infections

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2007.01377.X

21 January 2018

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2007.01377.X

21 January 2018

Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2007.01377.X

21 January 2018

An EORTC multicentre prospective survey of invasive aspergillosis in haematological patients: diagnosis and therapeutic outcome. EORTC Invasive Fungal Infections Cooperative Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2007.01377.X

21 January 2018

Caspofungin as first line therapy of pulmonary invasive fungal infections in 32 immunocompromised patients with hematologic malignancies.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2007.01377.X

21 January 2018

Caspofungin treatment in severely ill, immunocompromised patients: a case-documentation study of 118 patients.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2007.01377.X

21 January 2018

Evaluation of serum sandwich enzyme-linked immunosorbent assay for circulating galactomannan during caspofungin therapy: results from the caspofungin invasive aspergillosis study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2007.01377.X

21 January 2018

Invasive fungal infections after allogeneic peripheral blood stem cell transplantation: incidence and risk factors in 395 patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2007.01377.X

21 January 2018

Identifiers

10.1111/J.1439-0507.2007.01377.X

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44952892&oldid=1516394668"